オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - gabapentin, quantity: 400 mg - capsule - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; purified water; sodium lauryl sulfate; titanium dioxide; iron oxide red; iron oxide yellow - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - gabapentin, quantity: 300 mg - capsule - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; purified water; sodium lauryl sulfate; titanium dioxide; iron oxide yellow - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - gabapentin, quantity: 100 mg - capsule - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; purified water; sodium lauryl sulfate; titanium dioxide - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. gabapentin is indicated for the treatment of neuropathic pain.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - furosemide, quantity: 20 mg - tablet - excipient ingredients: magnesium stearate; sodium starch glycollate type a; pregelatinised maize starch; maize starch; lactose monohydrate - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - furosemide, quantity: 40 mg - tablet - excipient ingredients: sodium starch glycollate type a; maize starch; lactose monohydrate; magnesium stearate; pregelatinised maize starch - oedema frusemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. frusemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.,parenteral therapy with frusemide should be reserved for patients unable to take oral medication or for patients in emergency clinical situations. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, frusemide is indicated by the intravenous or intramuscular route. parenteral use should be replaced with oral frusemide as soon as practical.,hypertension oral frusemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with frusemide alone.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - hydroxychloroquine sulfate, quantity: 200 mg - tablet - excipient ingredients: colloidal anhydrous silica; calcium hydrogen phosphate; magnesium stearate; hypromellose; polysorbate 80; pregelatinised maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - rheumatoid arthritis; mild systemic and discoid lupus erythematosus; the suppression and treatment of malaria.

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - quizalofop-p-ethyl; liquid hydrocarbon - emulsifiable concentrate - quizalofop-p-ethyl phenoxy acids-propionics active 200.0 g/l; liquid hydrocarbon solvent other 759.0 g/l - herbicide

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sipcam pacific australia pty. limited - butroxydim - water dispersible granule - butroxydim cyclohexanediones active 250.0 g /kg - herbicide

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - metformin hydrochloride, quantity: 850 mg - tablet, film coated - excipient ingredients: maize starch; povidone; colloidal anhydrous silica; magnesium stearate; hypromellose; titanium dioxide; propylene glycol; macrogol 6000; purified talc; sodium starch glycollate type a - metformin is indicated in the treatment of type 2 diabetes mellitus in adults, children from 10 years of age and adolescents, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. for adult patients, metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents or as adjuvant therapy in insulin requiring type 2 diabetes.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

ipca pharma (nz) pty limited - furosemide 20mg - tablet - 20 mg - active: furosemide 20mg excipient: lactose monohydrate magnesium stearate maize starch pregelatinised maize starch sodium starch glycolate - furosemide is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. furosemide is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired.